Free Trial

Marshall Wace LLP Decreases Stake in Evolv Technologies Holdings, Inc. (NASDAQ:EVLV)

Evolv Technologies logo with Computer and Technology background

Marshall Wace LLP lessened its position in shares of Evolv Technologies Holdings, Inc. (NASDAQ:EVLV - Free Report) by 62.5% in the 2nd quarter, according to its most recent filing with the Securities & Exchange Commission. The institutional investor owned 730,256 shares of the company's stock after selling 1,217,357 shares during the period. Marshall Wace LLP owned about 0.47% of Evolv Technologies worth $1,862,000 as of its most recent SEC filing.

Other large investors also recently modified their holdings of the company. MCF Advisors LLC boosted its holdings in Evolv Technologies by 84.5% in the first quarter. MCF Advisors LLC now owns 6,549 shares of the company's stock valued at $29,000 after purchasing an additional 3,000 shares in the last quarter. Sequoia Financial Advisors LLC purchased a new position in shares of Evolv Technologies in the 1st quarter valued at $45,000. Foundations Investment Advisors LLC purchased a new position in shares of Evolv Technologies in the 2nd quarter valued at $30,000. Sierra Summit Advisors LLC acquired a new stake in Evolv Technologies during the 4th quarter worth $71,000. Finally, Worth Financial Advisory Group LLC lifted its position in Evolv Technologies by 42.0% in the second quarter. Worth Financial Advisory Group LLC now owns 15,000 shares of the company's stock valued at $38,000 after acquiring an additional 4,435 shares during the last quarter. 66.65% of the stock is owned by hedge funds and other institutional investors.

Evolv Technologies Stock Performance

Evolv Technologies stock traded down $0.03 during midday trading on Friday, hitting $3.79. 4,283,123 shares of the company's stock were exchanged, compared to its average volume of 1,537,750. The stock has a market cap of $591.57 million, a price-to-earnings ratio of -6.21 and a beta of 1.25. Evolv Technologies Holdings, Inc. has a 12-month low of $2.01 and a 12-month high of $5.73. The firm's 50 day simple moving average is $3.72 and its 200 day simple moving average is $3.42.

Evolv Technologies (NASDAQ:EVLV - Get Free Report) last released its quarterly earnings results on Thursday, August 8th. The company reported $0.02 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of ($0.13) by $0.15. The firm had revenue of $25.54 million for the quarter, compared to analyst estimates of $23.57 million. Evolv Technologies had a negative return on equity of 28.57% and a negative net margin of 21.42%. On average, equities research analysts forecast that Evolv Technologies Holdings, Inc. will post -0.26 EPS for the current fiscal year.

Analyst Ratings Changes

Separately, Northland Securities cut their target price on Evolv Technologies from $6.50 to $5.50 and set an "outperform" rating on the stock in a research report on Monday, August 12th. One investment analyst has rated the stock with a hold rating and four have given a buy rating to the company. According to MarketBeat.com, the company presently has a consensus rating of "Moderate Buy" and a consensus price target of $5.75.

Get Our Latest Research Report on Evolv Technologies

About Evolv Technologies

(Free Report)

Evolv Technologies Holdings, Inc provides artificial intelligence (AI)-based weapons detection for security screening in the United States and internationally. Its products include Evolv Express, a touchless security screening system designed to detect firearms, improvised explosive devices, and tactical knives; and Evolv Insights that provides self-serve access, insights regarding visitor flow and arrival curves, location specific performance, system detection performance, and alarm statistics.

Read More

Institutional Ownership by Quarter for Evolv Technologies (NASDAQ:EVLV)

Should you invest $1,000 in Evolv Technologies right now?

Before you consider Evolv Technologies, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Evolv Technologies wasn't on the list.

While Evolv Technologies currently has a "Moderate Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Reduce the Risk Cover

Market downturns give many investors pause, and for good reason. Wondering how to offset this risk? Click the link below to learn more about using beta to protect yourself.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Broadcom’s Momentum Returns: Will It Reach New Highs?
Toyota’s Big Bet on Joby: Will Air Taxis Revolutionize Travel by 2025?
UnitedHealth Group: A Healthcare Giant with Strong Dividends

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines